Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
The board or what the message board has turned into
:)
https://www.ft.com/content/68858ec0-90d3-11e9-b7ea-60e35ef678d2
This is worth a watch from the BBC (no longer on iplayer). "The truth about antibiotics". Explains why big pharma is avoiding antibiotic research
https://www.dailymotion.com/video/x71l6vl
Without news as September draws nearer then I suspect it will drop further. I am also tempted to average down again but can see it in the 2's before we get news. We are also in that difficult summer period where it is hard to do business....."Sell in May and go away" and all that!
The rpoblem with that is MTFB will get a really bad deal. If they don't agree to the terms set by the partner they are dead in the water. The only other options is to double or more the shares in issue and nobody wants that
I think the best outcome for LTH's at this stage is someone swooping in and potentially buying the company and all the research. They could probably get it for £20 million....given the amount spent to get it to this stage and the fact it isn't an outright rejection then it may appeal.
To me it's more appealing than dragging it out for another year, massive dilution/debt and paying this incompetent lot
....is all you can do as the information coming out of the company is sketchy at best. I can understand why until the minutes came out, but the only reason not to make that fully public cannot be good.
£11 million mcap and probably need the best part of that to get through the trials.....The dilution would be ridiculous
Any institutional investors or potential investment partners willing to jump in will probably want to put their own people in there as current bod arent cutting it.
Every single post on the first page is currently about him of a response too him. He is winning
I believe there will be a need for more trials given all the potential future uses and partnerships painting a potential larger sales pipeline and making them more investable. Hopefully I'm wrong as I'm averaging 20p, and they are just following a process as if the drug had passed
They're playing this out for the institutions not PI's. Making the long term proposition look good and enabling them to get in cheap on any cash raise. They could've kept completely stum, let fomo kick in before the minutes and raise at a higher price. Not very appealing to the bigger boys
I'm very dubious of anything anyone says, not just on twitter. Even if you take his word, they've been confident of approval all along and the 'no surprises' bit could just mean they were expecting anther trial
No idea if he is really there or not
https://twitter.com/ScottStockz/status/1131170961930244096
"#MTFB
AGM update
‘FDA meeting went as planned with no surprises - we are still confident of approval but still need to wait for the minutes’
Booooooooooooom
??
"
Selling, not drinking....although it kind of works
Its different this time. There will be fomo, but also people who have averaged down drinking when they break even
I don't think there's much point arguing about the science or the history. It's the main reason everyone is invested The performance of the bod is my main concern. No plan for crl pre decision, no skin in the game, poor communication and high cash burn. I'd like to see them buying in. If they don't after the meeting I've hopefully averaged down enough to get out even or with a small loss when the fomo kicks in. I might leave a bit in as I've been in a couple of years
If the FDA had no inention of ever approving it, why did they give it fast track status and a free ride?
I'm at 19p also. It might get a bit sticky in that range if others have done the same and decide to reduce holding
Nasdaq bouncing back
nearly half the placing shares churned then
I'm a LTH but alsoa realist. A sensible BOD would have funded for the 6 to 12 months post the decision date, even if they had a commercial partner in the wings. Ready for any outcome with mimimal dilution. It may also have given confidence to the major holders that they could get past the CRL to approval without dumping stock
We are where we are, it's still a needed drug which I think will eventually be approved. Getting it over the line to commercialisation as an MTFB drug is a lot less certain
vitriolic /ˌvɪtrɪˈɒlɪk/ adjective filled with bitter criticism or malice. You might also want to look up the word 'irony'